 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 220.01 |
2.07 % |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 19.69 |
2.39 % |
$ 920 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
BioMarin Pharmaceutical
BMRN
|
88.9 |
$ 55.38 |
2.38 % |
$ 10.6 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |
 |
Cara Therapeutics
CARA
|
52.4 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
239 |
$ 8.24 |
0.67 % |
$ 110 M |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
1.1 K |
$ 47.3 |
1.87 % |
$ 4.25 B |
Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
81.5 K |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
CytomX Therapeutics
CTMX
|
12.3 |
$ 4.39 |
3.42 % |
$ 606 M |
USA |
 |
ChemoCentryx
CCXI
|
3.1 |
- |
- |
$ 3.74 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 |
- |
- |
$ 2.02 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Eton Pharmaceuticals
ETON
|
39.1 |
$ 24.37 |
6.1 % |
$ 656 M |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 |
$ 4.54 |
5.29 % |
$ 870 M |
Canada |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Brickell Biotech
BBI
|
254 |
- |
-5.38 % |
$ 6.06 M |
USA |